Crestal bone loss and oral implants

Clin Implant Dent Relat Res. 2012 Dec;14(6):783-91. doi: 10.1111/cid.12013. Epub 2012 Nov 30.

Abstract

Background: A consensus meeting was arranged to critically analyze whether the high figures of peri-implantitis at machined implants that recently have been reported in the literature are valid also for modern implants.

Purpose: The aims of this paper were to present the outcomes from the consensus meeting and to evaluate recent long-term clinical studies on modern implants with regard to frequency of peri-implant infection.

Materials and methods: Ten different studies of three modern implant brands of moderately rough surfaces with 10-year or longer follow-up times were found through a PubMed and manual search.

Results: It was concluded that bleeding on probing or probing depths are weak indicators of crestal bone loss (CBL); that CBL occurs for many other reasons than infection; that implant-, clinician-, and patient-related factors contribute to CBL; and that modern oral implants outperform older devices. Based on a literature search, the frequency of implants with reported peri-implant infection and significant bone loss leading to implant removal or other surgical intervention was on average 2.7% during 7 to 16 years of function.

Conclusion: The summed frequency of peri-implantitis and implant failure is commonly less than 5% over 10 years of follow-up for modern implants when using established protocols.

MeSH terms

  • Alveolar Bone Loss / diagnosis*
  • Alveolar Bone Loss / etiology*
  • Coated Materials, Biocompatible / adverse effects
  • Consensus Development Conferences as Topic
  • Dental Implants / adverse effects*
  • Dental Prosthesis Design*
  • Dental Restoration Failure*
  • Humans
  • Peri-Implantitis / diagnosis
  • Peri-Implantitis / etiology
  • Risk Factors
  • Surface Properties
  • Titanium

Substances

  • Coated Materials, Biocompatible
  • Dental Implants
  • Titanium